Shihan Xu
About Shihan Xu
Shihan Xu is a QC Analyst at Bristol Myers Squibb with a strong background in toxicology and experience in clinical research and biochemistry.
Current Role at Bristol Myers Squibb
Shihan Xu is currently serving as a QC Analyst at Bristol Myers Squibb in New Jersey, United States. He started his tenure with the company in October 2020. In this role, Shihan focuses on enhancing the efficiency and capabilities of the pharmaceutical industry. His expertise in toxicology plays a crucial part in ensuring the quality and safety of pharmaceutical products.
Work Experience at TongShuGene
Before his current role, Shihan Xu worked at TongShuGene as a Clinical Research Assistant in Shanghai City, China. His stint lasted for 6 months from 2018 to 2019. During this period, he was involved in clinical research activities that contributed to furthering medical knowledge and development in the field of genetics.
Research Assistant at Haema Medicine
Shihan Xu also held the position of Research Assistant at Haema Medicine in Shanghai City, China, for 5 months in 2018. This role involved conducting research that would support advancements in medical treatments and methodologies. His work here added to his rich background in research and application in the medical field.
Educational Background
Shihan Xu has an extensive educational background with a Master's degree in Toxicology from Columbia University Mailman School of Public Health, which he completed in one year from 2019 to 2020. Prior to that, he obtained a Bachelor's degree in Biochemistry from Purdue University, where he studied from 2014 to 2018. This solid educational foundation has equipped him with the necessary skills and knowledge to excel in his field.
Experience at Purdue University
From 2015 to 2018, Shihan Xu worked as a Research Assistant at Purdue University. Over these three years, he contributed to various research projects, gaining hands-on experience which significantly enriched his expertise in biochemistry and toxicology. This period was marked by intensive research activities that helped lay the groundwork for his future roles in the pharmaceutical and medical research sectors.